TUBA1B and cancer: The positive correlations between TUBA1B and immunosuppressive factors suggest its potential role in establishing an immunosuppressive TME, offering valuable insights for developing targeted therapies to modulate the TME and enhance immune-based cancer control strategies for improved patient outcomes.